ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored

March 5, 1993

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

Duke Scientists Develop 3D Mammography Using CT

February 24, 2006